Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Mar 27 2022 | HFSA President's Message: March 2022 HFSA News President's Updates Read More Mar 16 2022 | Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease Industry News In The News Industry Read More Mar 14 2022 | New Episode of the Heart Failure Beat Explores Guideline-Directed Medical Therapy in HF – Evidence vs. Practicality HFSA News Podcasts Provider Education Read More Mar 9 2022 | The definition of heart failure—a patient’s perspective Patient News Heart Failure Awareness 365 Patient Resource Read More Mar 2 2022 | US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 69 Page 70 Page 71 Page 72 Current page 73 Page 74 Page 75 Page 76 Page 77 … Next page Next › Last page Last »
Mar 16 2022 | Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease Industry News In The News Industry Read More
Mar 14 2022 | New Episode of the Heart Failure Beat Explores Guideline-Directed Medical Therapy in HF – Evidence vs. Practicality HFSA News Podcasts Provider Education Read More
Mar 9 2022 | The definition of heart failure—a patient’s perspective Patient News Heart Failure Awareness 365 Patient Resource Read More
Mar 2 2022 | US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Industry News In The News Industry Read More
